Literature DB >> 20691874

Induced pluripotent stem cells.

Holm Zaehres1, Jeong Beom Kim, Hans R Schöler.   

Abstract

Reprogramming of mouse and human somatic cells into induced pluripotent stem (iPS) cells has been possible with retroviral expression of the pluripotency-associated transcription factors Oct4, Sox2, Nanog, and Lin28 as well as Klf4 and c-Myc. iPS cells hold great potential as a model for diseases from the perspective of the individual patient and as an alternative source of pluripotent stem cells for therapeutic applications. In this chapter, we discuss how the use of retroviruses as well as other expression vectors, protein transduction, and small molecules can effectively and efficiently induce pluripotent stem cells from a variety of mouse and human starting somatic cell populations. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20691874     DOI: 10.1016/S0076-6879(10)76018-3

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  7 in total

Review 1.  New routes for transgenesis of the mouse.

Authors:  José E Belizário; Priscilla Akamini; Philip Wolf; Bryan Strauss; José Xavier-Neto
Journal:  J Appl Genet       Date:  2012-05-09       Impact factor: 3.240

Review 2.  Thinking outside the liver: induced pluripotent stem cells for hepatic applications.

Authors:  Mekala Subba Rao; Mitnala Sasikala; D Nageshwar Reddy
Journal:  World J Gastroenterol       Date:  2013-06-14       Impact factor: 5.742

3.  The histone methyltransferase inhibitor BIX01294 enhances the cardiac potential of bone marrow cells.

Authors:  Nadejda V Mezentseva; Jinpu Yang; Keerat Kaur; Grazia Iaffaldano; Mathieu C Rémond; Carol A Eisenberg; Leonard M Eisenberg
Journal:  Stem Cells Dev       Date:  2012-11-07       Impact factor: 3.272

4.  Self-renewal induced efficiently, safely, and effective therapeutically with one regulatable gene in a human somatic progenitor cell.

Authors:  Kwang S Kim; Hong J Lee; Han S Jeong; Jianxue Li; Yang D Teng; Richard L Sidman; Evan Y Snyder; Seung U Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-04       Impact factor: 11.205

5.  Nitric oxide receptor soluble guanylyl cyclase undergoes splicing regulation in differentiating human embryonic cells.

Authors:  Vladislav G Sharin; Kalpana Mujoo; Alexander Y Kots; Emil Martin; Ferid Murad; Iraida G Sharina
Journal:  Stem Cells Dev       Date:  2010-12-06       Impact factor: 3.272

6.  Erythroid differentiation of human induced pluripotent stem cells is independent of donor cell type of origin.

Authors:  Isabel Dorn; Katharina Klich; Marcos J Arauzo-Bravo; Martina Radstaak; Simeon Santourlidis; Foued Ghanjati; Teja F Radke; Olympia E Psathaki; Gunnar Hargus; Jan Kramer; Martin Einhaus; Jeong Beom Kim; Gesine Kögler; Peter Wernet; Hans R Schöler; Peter Schlenke; Holm Zaehres
Journal:  Haematologica       Date:  2014-10-17       Impact factor: 9.941

7.  Induced Overexpression of THAP11 in Human Fibroblast Cells Enhances Expression of Key Pluripotency Genes.

Authors:  Saeid Ziaei; Mostafa Rezaei-Tavirani; Abdolreza Ardeshirylajimi; Ehsan Arefian; Masoud Soleimani
Journal:  Galen Med J       Date:  2019-08-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.